Paper29142012
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T and 18 others. Circulation, 2018. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Papers, record 29142012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29142012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
- PubMed
- Publication types
- Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atrial Function, Left | Major topic |
| Atrial Pressure | Major topic |
| Cardiac Catheterization | Major topic |
| Cardiac Catheters | Major topic |
| Heart Failure | Major topic |
| Heart-Assist Devices | Major topic |
| Stroke Volume | Major topic |
| Ventricular Function, Left | Major topic |
| Aged | |
| Australia | |
| Europe | |
| Exercise Tolerance | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Prosthesis Design | |
| Pulmonary Wedge Pressure | |
| Recovery of Function | |
| Time Factors | |
| Treatment Outcome | |
| United States |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02600234 | REDUCE LAP-HF RANDOMIZED TRIAL I | Derived from the trial | Yes |
Source ClinicalTrials.gov
Cited by133
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930915 | Interatrial Shunt Devices in Heart Failure: A Therapy in Search of the Right Patient. | J Cardiovasc Dev Dis | 2026 | https://conductscience.org/library/papers/42930915 | PubMed |
| 42842133 | Novel device-based and catheter-directed therapies for heart failure with preserved ejection fraction. | Cardiovasc Interv Ther | 2026 | https://conductscience.org/library/papers/42842133 | PubMed |
| 42578452 | Type 2 diabetes in heart failure with preserved and mildly reduced ejection fraction: insights from the REDUCE-LAP-HF II trial. | ESC Heart Fail | 2026 | https://conductscience.org/library/papers/42578452 | PubMed |
| 42428489 | Case Report: Managing a patent foramen ovale complicated by severe left-sided heart failure and multiple thromboembolic events. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42428489 | PubMed |
| 42364251 | Right ventricular to pulmonary artery coupling and clinical outcomes after interatrial shunting in heart failure: exploratory analysis of the PRELIEVE study. | ESC Heart Fail | 2026 | https://conductscience.org/library/papers/42364251 | PubMed |
| 41984824 | Heart failure and preserved ejection fraction: pathophysiology, clinical assessment, and management of exercise intolerance. | Eur Heart J | 2026 | https://conductscience.org/library/papers/41984824 | PubMed |
| 41887649 | Comparison of the efficacy of non-pharmacological interventions for patients with heart failure with preserved ejection fraction: protocol for a systematic review and network meta-analysis of randomised controlled trials. | BMJ Open | 2026 | https://conductscience.org/library/papers/41887649 | PubMed |
| 41682980 | Patent Foramen Ovale Does Not Affect Left Atrial Pressure in Atrial Fibrillation Ablation Patients. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682980 | PubMed |
| 41465899 | Iatrogenic atrial septal defect following transcatheter edge-to-edge mitral valve repair: A systematic review and meta-analysis. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41465899 | PubMed |
| 41326847 | Atrial shunt therapy for heart failure: an update review. | Heart Fail Rev | 2025 | https://conductscience.org/library/papers/41326847 | PubMed |
| 41181650 | Efficacy and safety of interatrial shunt treatment for heart failure: A systematic review and meta-analysis. | World J Cardiol | 2025 | https://conductscience.org/library/papers/41181650 | PubMed |
| 41000019 | Easing the Strain: Atrial Function After Atrial Shunting. | Circ Heart Fail | 2025 | https://conductscience.org/library/papers/41000019 | PubMed |
| 40896284 | Time's imprint on the left atrium: aging and atrial myopathy. | J Cardiovasc Aging | 2025 | https://conductscience.org/library/papers/40896284 | PubMed |
| 40894364 | Atrial Shunting for Heart Failure. | Struct Heart | 2025 | https://conductscience.org/library/papers/40894364 | PubMed |
| 40857067 | Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/40857067 | PubMed |
| 40511661 | Improvement of Hemodynamics and Quality of Life Before and After Interatrial Shunt Devices Implantation for Chronic Heart Failure: A Systematic Review and Meta-analysis. | Curr Cardiol Rev | 2025 | https://conductscience.org/library/papers/40511661 | PubMed |
| 40180634 | Device-based therapies for heart failure with preserved ejection fraction. | Heart Fail Rev | 2025 | https://conductscience.org/library/papers/40180634 | PubMed |
| 40155120 | Diastolic Mitral Regurgitation With Interatrial Left-to-Right Shunt. | JACC Case Rep | 2025 | https://conductscience.org/library/papers/40155120 | PubMed |
| 40121540 | Determinants of cardiac output in health and heart failure. | Exp Physiol | 2025 | https://conductscience.org/library/papers/40121540 | PubMed |
| 40061421 | Understanding Right Heart Flow: Implications for Interatrial Shunt Device Therapy in Heart Failure. | J Soc Cardiovasc Angiogr Interv | 2025 | https://conductscience.org/library/papers/40061421 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29142012
GET https://conductscience.org/api/papers/v1/29142012/cited_by?page=2